Literature DB >> 12086800

Is the NICE process flawed?

I Benjamin, G Poston, D Sherlock.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12086800     DOI: 10.1016/S0140-6736(02)08933-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

Review 1.  Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle.

Authors:  R S Taylor; M F Drummond; G Salkeld; S D Sullivan
Journal:  BMJ       Date:  2004-10-23

2.  Perindopril for improving cardiovascular events.

Authors:  James J DiNicolantonio; James H O'Keefe
Journal:  Vasc Health Risk Manag       Date:  2014-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.